Loading
Life sciences · Review
Expert Review of Anticancer Therapy · October 31, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Review.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
INTRODUCTION: Gynecologic cancers represent 16% of cancers in women worldwide. With the advent of novel therapeutics, gynecologic cancer patients are increasingly experiencing longer disease-free intervals or cure. Optimizing survivorship care for patients can improve post-cancer quality of life. AREAS COVERED: We searched PubMed and utilized OpenEvidence to identify citations relevant to gynecologic cancer survivorship. Gynecologic cancer has a distinct impact on sexual health and fertility. We characterize and explore interventions for fertility management, sexual dysfunction, and premature menopause. Physical concerns following systemic therapy, radiation, and surgery can have lasting effects into survivorship. We emphasize the most common post-operative chronic morbidities including ostomies and lymphedema, sequalae of pelvic radiation, and chronic health conditions due to immunotherapy and targeted therapy. Emotional and psychosocial aspects of survivorship both impact and are impacted by the physical and sexual domains of survivorship. We discuss mental health, financial, and interpersonal implications of survivorship and avenues to improve psychosocial outcomes after gynecologic cancer. EXPERT OPINION: Survivorship in gynecologic cancer will continue to gain importance as the field makes gains in therapeutic treatments and early diagnosis and treatment. Subsequent research will need to focus on models of care implementation including virtual components and coordination across health systems.